A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis

Clinical trial NCT07499700 · RECRUITING

Trial details

NCT number: NCT07499700
Sponsor: Bio-Thera Solutions
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Minimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)

Start date: 2025-10-26
Primary completion: 2030-10-26
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.